A series of new 1,2-dihydro and 1,2,3,4-tetrahydroquinolines, synthesized f
rom the corresponding propargylaniline intermediates, have been developed a
s antioxidants for the potential treatment of pathologies implicating centr
al oxidative stress. (C) 2000 Elsevier Science Ltd. All rights reserved.